Identification and Semi -Quantification of ER/PR Proteins Expression
Identification and Semi -Quantification of ER/PR Proteins Expression
The purpose of the study is the identification and quantification of proteins expression
 level in breast cancer tissues.

 The imaging system is intended for diagnostic use as an aid to the pathologist in the
 detection, counting and classifying ER/PR IHC stained samples.
The anti ER/PR Kit is a semi-quantitative immunohistochemical (IHC) assay to identify the
 progesterone (PR) and estrogen (ER) expressions in formalin-fixed, paraffin-embedded human
 breast cancer tissue specimens. Results from the ER/PR test is indicated as an aid in the
 assessment of the hormones status of breast cancer patients. While the ER/PR kit provides the
 antibodies that offer direct visualization and semi-quantification of the protein expression
 through a brightfield microscope, the GenASIs GoPath system is designed to complement the
 routine workflow of the pathologist in the review of immunohistochemically stained histologic
 slides.
Inclusion Criteria:

 -  Women having breast cancer

 Exclusion Criteria:

 -  others